Novel opioid antagonists for opioid-induced bowel dysfunction
Authors:
- 12 June 2011
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Investigational Drugs
- Vol. 20 (8) , 1047-1056
Abstract
(2011). Novel opioid antagonists for opioid-induced bowel dysfunction. Expert Opinion on Investigational Drugs: Vol. 20, No. 8, pp. 1047-1056. doi: 10.1517/13543784.2011.592830Keywords
This publication has 36 references indexed in Scilit:
- ▼Targinact – opioid pain relief without constipation?Drug and Therapeutics Bulletin, 2010
- Opioid receptors in the gastrointestinal tractRegulatory Peptides, 2009
- Combined prolonged-release oxycodone and naloxone improves bowel function in patients receiving opioids for moderate-to-severe non-malignant chronic pain: a randomised controlled trialExpert Opinion on Pharmacotherapy, 2009
- The Prevalence, Severity, and Impact of Opioid-Induced Bowel Dysfunction: Results of a US and European Patient Survey (PROBE 1)Pain Medicine, 2009
- Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer painCurrent Medical Research and Opinion, 2008
- Methylnaltrexone, a new peripherally acting mu-opioid receptor antagonist being evaluated for the treatment of postoperative ileusExpert Opinion on Investigational Drugs, 2008
- Opioid-Induced Bowel DysfunctionJournal of Pain and Symptom Management, 2008
- Pathogenesis and clinical and economic consequences of postoperative ileusAmerican Journal of Health-System Pharmacy, 2007
- Opioid-induced bowel dysfunction: prevalence, pathophysiology and burdenInternational Journal Of Clinical Practice, 2007
- Alvimopan, for Postoperative Ileus Following Bowel ResectionAnnals of Surgery, 2007